Associate Professor of Pediatrics
University of Medicine and Dentistry of New Jersey
Director, Pediatric Gastroenterology
Goryeb Children’s Hospital/Atlantic Health
Morristown, New Jersey

Joel R. Rosh completed a medical degree at Albert Einstein College of Medicine in New York. His postdoctoral training included an internship and residency in the Babies Hospital–Columbia Presbyterian Medical Center Department of Pediatrics and a fellowship in pediatric gastroenterology at Mt. Sinai Hospital in New York. Prior to joining the faculty at University of Medicine and Dentistry of New Jersey, Dr. Rosh served in the Department of Pediatrics at Mt. Sinai Hospital and Columbia Presbyterian Hospital in New York.

Certified by the American Board of Pediatrics in pediatric gastroenterology and nutrition, and by the National Board of Medical Examiners, Dr. Rosh is a member of several professional societies, including the American Academy of Pediatrics (AAP), the Crohn’s & Colitis Foundation of America (CCFA), and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). He has served on numerous advisory bodies, including as National Vice Chairman of the AAP GI Practice Committee and National Chairman of the CCFA Pediatric Education Committee. Additionally, Dr. Rosh is a Founder of the New Jersey Pediatric GI Society and a Fellow of the American College of Gastroenterology and the American Gastroenterological Association (AGA). Among Dr. Rosh’s many honors and awards are CCFA Physician of the Year, New Jersey Chapter (2004); New Jersey Pediatric Society Physician Recognition Award (2002); and selection to several best-doctors lists, including New Jersey Monthly’s Top Doctors in New Jersey (1998-2011), Best Doctor, Inc’s Best Doctors in America (2000–2011), and Castle Connolly’s New York Metro Area Top Doctor (1998–2011).

Dr. Rosh is well published in the peer-reviewed literature. He is a reviewer for several journals and a member of the editorial boards of Journal of Pediatric Gastroenterology and Nutrition and International Journal of Pediatrics. Dr. Rosh is active in research, and he has served as principal investigator on several government- and industry-funded studies. A highly sought presenter, Dr. Rosh has lectured extensively on topics relating to pediatric gastroenterological pathologies.

Pediatric Gastroenterology and Nutrition

The Division of Gastroenterology and Nutrition at Goryeb Children's Hospital offers a full range of services for infants, children, and adolescents with gastrointestinal, liver, pancreatic, and nutritional disorders.

Physicians work closely with referring physicians on both an outpatient and inpatient basis in the evaluation and management of problems including the following:
• Abdominal pain
• Constipation
• Diarrhea and malabsorption
• Vomiting and gastroesophageal reflux
• Peptic ulcer disease and H.pylori
• Gastrointestinal bleeding
• Inflammatory bowel disease (Crohn's disease and ulcerative colitis)
• Hepatitis and liver disorders
• Cystic fibrosis
• Pancreatitis
• Feeding intolerance and food allergy
• Short bowel syndrome
• Growth and nutrition issues
• Celiac (Gluten sensitivity)

A nurse practitioner/nurse educator will follow up your initial inquiry to answer your questions or concerns. You may also see the nurses at your initial visit or follow-up appointments. Together with your child's gastroenterologists, the professional staff will map out a plan of care for your child.

 Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease (RS)

The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.

Estimated Enrollment: 1100
Study Start Date: November 2008
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

Ages Eligible for Study: up to 16 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Sampling Method: Probability Sample

 Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

The purpose of the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry is to study the contemporary natural history of children <16 years of age newly diagnosed with inflammatory bowel disease. The project follows these children quarterly from diagnosis examining clinical, laboratory, and humanistic outcomes. Genetic and serologic monitoring is performed on the study population.

Estimated Enrollment: 1000
Study Start Date: January 2002
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)

Ages Eligible for Study: 1 month to 16 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

 Predicting Response to Standardized Pediatric Colitis Therapy (PROTECT)

This is a multi-center, open-label study to determine the safety and effectiveness (how well it works) of two standardized treatments called "mesalamine" (Pentasa®) and "prednisone" in children with newly diagnosed UC. Standardized treatments are types of treatments agreed upon and used by many qualified doctors. The medications being used in this study are considered "standard of care". Currently the ways in which these medicines are used (doses, frequency of dosing) may vary from site to site. This study will determine response to a standardized way of giving these medicines.

This study will also identify biomarkers for ulcerative colitis. Biomarkers are things that doctors can find in blood, stool, or bowel tissue that indicate how much inflammation there is in the bowel, how the inflammation is produced, and whether the inflammation is responding to treatment. Collecting response and remission (free of symptoms) information on these standardized treatments and the "biomarkers" can possibly help doctors create a model, or plan to know which children with UC may respond quickly, or which children may develop complications.

Estimated Enrollment: 430
Study Start Date: June 2012
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)

 Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

This study is designed to evaluate the performance of VCE in the assessment of mucosal inflammation 6 months after the first VCE procedure

Estimated Enrollment: 75
Study Start Date: August 2013
Estimated Study Completion Date: July 2016
Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)